|
|
Thomson Financial Business Description:
| The group's principle activity is designing & developing of medical devices for continuous monitoring of glucose in people with diabetes. It has developed proprietary technology and expertise that enable it to develop two continuous glucose monitoring systems: a short-term system with a sensor that can be inserted by a patient and used continuously for three days, and a long-term system with a sensor that can be implanted by a physician in a short outpatient procedure requiring only local anesthesia, and can be used for up to one year. The Group received notification from the FDA that our PMA was accepted as filed and granted expedited review status. The group commenced initial commercial shipments of its STS in the United States on Mar-28, 2006. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on DexCom, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
